• Home
  • Stocks
  • Krebs Biochemicals & Industries Ltd.

Krebs Biochemicals & Industries Ltd.

View in App
82.85 +1.40 ▲1.7%

11 December 2023, 03:32:02 PM
Volume: 11,462

Company Profile

View details >>
Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.krebsbiochem.com
Market Cap 178.97 Cr.
Enterprise Value(EV) 364.45 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) -9.92 Trailing Twelve Months Ending 2023-09
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2023-09
Industry PE 38.52 Trailing Twelve Months Ending 2023-09
Book Value / Share -50.26 Trailing Twelve Months Ending 2023-09
Price to Book Value -1.65 Calculated using Price: 83.01
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 2.16 Cr. 21,560,586 Shares
FaceValue 10
About Krebs Biochemicals & Industries Ltd.
Krebs Biochemicals & Industries (KBIL) was established in the year 1991 as a Public Limited Company with the main objective of establishing commercially viable biotech processes with applications in Medicine, Agriculture Industry. The company has pioneered in the fermentation technology over the last decade.

Krebs Biochemicals & Industries Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Krebs Biochemicals & Industries Ltd. Performance

View details >>
1 Day
+1.72%
1 Week
+3.43%
1 Month
-4.50%
3 Month
+28.65%
6 Month
+29.55%
1 Year
-29.73%
2 Year
-49.94%
5 Year
-18.02%
10 Year

Krebs Biochemicals & Industries Ltd. Fundamental Ratios

View details >>
9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) -683.34 -296.70
Return on Capital Employed (%) -4.33 -25.38 -27.13 -28.95 -35.41 -56.96 -40.28 -57.38 -28.59
Return on Assets (%) -6.44 -14.60 -13.46 -14.38 -14.92 -20.91 -19.36 -25.51 -13.54

Krebs Biochemicals & Industries Ltd. Balance Sheet

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 18 13 1 -18 -14 -25 -43 -75 -99 -108
Non Curr. Liab. 60 74 89 101 102 116 154 187 225 231
Curr. Liab. 29 30 32 42 55 43 48 78 49 55
Minority Int.
Equity & Liab. 107 116 122 126 142 134 159 190 175 178
Non Curr. Assets 92 107 109 109 111 115 138 154 159 162
Curr. Assets 15 9 13 17 31 19 21 35 16 16
Misc. Exp. not W/O
Total Assets 107 116 122 126 142 134 159 190 175 178

Krebs Biochemicals & Industries Ltd. Profit and Loss

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09 Rs. Cr. TTM
Net Sales 1 4 34 48 33 54 60 52 46
Other Income 0 1 0 0 0 0 1 1 1 0
Total Income 0 2 4 34 48 34 54 61 53 46
Total Expenditure -5 -14 -12 -41 -58 -52 -71 -94 -68 -57
PBIDT -5 -11 -8 -7 -9 -18 -17 -33 -15 -11
Interest -4 -1 -3 -5 -6 -6 -6 -5 -3 -4
Depreciation -2 -4 -4 -4 -4 -5 -5 -6 -7 -7
Taxation
Exceptional Items 3 0 0 -1 0
PAT -8 -16 -16 -18 -20 -29 -28 -45 -25 -21
Adjusted EPS -8 -12 -11 -13 -12 -16 -14 -21 -11 -10

Krebs Biochemicals & Industries Ltd. Cash Flow

View details >>
Particulars 10 years 2014-09 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 49 -45 -15 -11 -6 4 -36 -15 -17 -25
Cash Fr. Inv. 0 -3 -4 -5 -3 -4 -10 -23 -23 -13
Cash Fr. Finan. -49 54 13 16 9 17 29 38 40 37
Net Change 0 6 -6 0 0 17 -17 1 -1 0
Cash & Cash Eqvt 0 6 0 0 0 17 0 1 0 0

Krebs Biochemicals & Industries Ltd. Shareholding Pattern

View details >>
9 Qtrs 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%)
Promoter 72.74 72.74 72.74 72.74 72.74 72.72 72.74 72.74 72.74
Public 27.26 27.26 27.26 27.26 27.26 27.28 27.26 27.26 27.26
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Krebs Biochemicals & Industries Ltd. Announcements

View details >>
Fri, 10 Nov 2023
Copy of Newspaper Publication
Krebs Biochemicals and Industries Limited has informed the Exchange about Copy of Newspaper Publication Unaudited Financial Results published in Newspaper for Q2 H1 FY24
Thu, 09 Nov 2023
Outcome of Board Meeting
Krebs Biochemicals and Industries Limited has informed the Exchange regarding Outcome of Board Meeting held on November 08, 2023.
Thu, 09 Nov 2023
Financial Result Updates
Krebs Biochemicals and Industries Limited has submitted to the Exchange, the financial results for the period ended September 30, 2023.

Krebs Biochemicals & Industries Ltd. Technical Scans

View details >>
Fri, 08 Dec 2023
Opening at Low Opening at Low
Closing Above Previous High Closing Above Previous High
Making Higher Highs for 2 Days Making Higher Highs for 2 Days
High Decrease in 1 Month High Decrease in 1 Month
High Increase in 3 Months High Increase in 3 Months

Krebs Biochemicals & Industries Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 296,437.84 1,241.40 +0.4%
Cipla Ltd. 98,444.27 1,202.30 -1.4%
Divi's Laboratories Ltd. 97,728.28 3,670.50 -0.3%
Dr. Reddy's Laboratories Ltd. 96,135.30 5,473.50 -5.0%
Apollo Hospitals Enterprise Ltd. 79,790.42 5,547.35 -0.1%
Mankind Pharma Ltd. 78,250.95 1,920.05 -1.7%
Torrent Pharmaceuticals Ltd. 69,508.23 2,078.35 +1.2%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-09 34.68 1,241.40 +0.4%
Cipla Ltd. Consolidated 2023-09 28.51 1,202.30 -1.4%
Divi's Laboratories Ltd. Consolidated 2023-09 73.38 3,670.50 -0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-09 18.88 5,473.50 -5.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-09 114.40 5,547.35 -0.1%
Mankind Pharma Ltd. Consolidated 2023-03 61.04 1,920.05 -1.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-09 52.11 2,078.35 +1.2%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-09 4.96 1,241.40 +0.4%
Cipla Ltd. Consolidated 2023-09 3.97 1,202.30 -1.4%
Divi's Laboratories Ltd. Consolidated 2023-09 7.71 3,670.50 -0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-09 3.77 5,473.50 -5.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-09 12.27 5,547.35 -0.1%
Mankind Pharma Ltd. Consolidated 2023-03 9.28 1,920.05 -1.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-09 10.36 2,078.35 +1.2%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,241.40 +0.4%
Cipla Ltd. Consolidated 2023-03 0.02 1,202.30 -1.4%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,670.50 -0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,473.50 -5.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 5,547.35 -0.1%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 1,920.05 -1.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,078.35 +1.2%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,241.40 +0.4%
Cipla Ltd. Consolidated 2023-03 12.85 1,202.30 -1.4%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,670.50 -0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,473.50 -5.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,547.35 -0.1%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,920.05 -1.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,078.35 +1.2%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,241.40 +0.4%
Cipla Ltd. Consolidated 2023-03 12.85 1,202.30 -1.4%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,670.50 -0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,473.50 -5.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,547.35 -0.1%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,920.05 -1.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,078.35 +1.2%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,241.40 +0.4%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,202.30 -1.4%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,670.50 -0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,473.50 -5.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 5,547.35 -0.1%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 1,920.05 -1.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,078.35 +1.2%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,241.40 +0.4%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,202.30 -1.4%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,670.50 -0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,473.50 -5.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 5,547.35 -0.1%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 1,920.05 -1.7%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,078.35 +1.2%

Krebs Biochemicals & Industries Ltd. FAQ's

What is Krebs Biochem.&Inds share price?
Can I buy Krebs Biochem.&Inds shares now?
What is the Market Cap of Krebs Biochem.&Inds?
What is the 52 Week High and Low of Krebs Biochem.&Inds?
What is the trend of Krebs Biochem.&Inds share price?